K. Schaefer-Eckart

发表

Clinical-scale single-step CD4+ and CD8+ cell depletion for donor innate lymphocyte infusion (DILI)

H. Einsele, B. Kimmel, M. Wilhelm, 2008, Bone Marrow Transplantation.

Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.

H. Einsele, M. Pfreundschuh, D. Niederwieser, 2016, Blood.

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT

H. Einsele, C. Meisner, T. Klingebiel, 2009, Bone Marrow Transplantation.

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

C. Hemmelmann, J. Finke, T. Luft, 2019, The Lancet. Haematology.

Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years

G. Ehninger, A. Hänel, M. Bornhäuser, 2021, Journal of Cancer Research and Clinical Oncology.

Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning

W. Hiddemann, K. Metzeler, K. Spiekermann, 2021, Haematologica.

Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years

G. Ehninger, A. Hänel, M. Bornhäuser, 2021, Journal of Cancer Research and Clinical Oncology.

Sex and body mass index but not CXCL12 801 G/A polymorphism determine the efficacy of hematopoietic cell mobilization: a study in healthy volunteer donors.

G. Ehninger, C. Thiede, A. Schmidt, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation

N. Schmitz, P. Reimer, B. Metzner, 2016, Blood Cancer Journal.

Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

U. Pichlmeier, D. Niederwieser, P. Dreger, 2022, American journal of hematology.

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor

W. Siegert, G. Ehninger, K. Höffken, 2003, Bone Marrow Transplantation.

Mito-FLAG with Ara-C as Bolus Vs. Continuous Infusion in Recurrent AML – Results of a Prospective Randomized Intergroup Study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemias (SAL)

D. Niederwieser, G. Ehninger, W. Aulitzky, 2008 .

Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells

H. Einsele, B. Kimmel, M. Wilhelm, 2014, Journal of Translational Medicine.

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

A. Ho, C. Junghanss, G. Ehninger, 2012, The Lancet.

Rationale and Design of GnG-Trial: A Randomized Phase-III Study to Compare Two Schedules of Gemtuzumab Ozogamicin as Adjunct to Intensive Induction Therapy and to Compare Double-Blinded Intensive Postremission Therapy with or Without Glasdegib in Older Patients with Newly Diagnosed AML

R. Schlenk, M. Görner, M. Kieser, 2021 .

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning

H. Einsele, A. Zander, U. Pichlmeier, 2012, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine.

P. Fenaux, L. Adès, U. Germing, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Therapeutic platelet transfusion for hypoproliferative thrombocytopenia – Authors' reply

H. Wandt, K. Schaefer-Eckart, 2013, The Lancet.

A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation

H. Wandt, M. Wilhelm, J. Birkmann, 2006, Bone Marrow Transplantation.

A Therapeutic Platelet Transfusion Strategy without Routine Prophylactic Transfusion Is Feasible and Safe and Reduces Platelet Transfusion Numbers Significantly: Preliminary Analysis of a Randomized Study in Patients after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantat

G. Ehninger, M. Schaich, M. Schubert, 2008 .

Two allogeneic hematopoietic stem cell transplantations without the use of blood-product support.

H. Wandt, M. Wilhelm, K. Schaefer-Eckart, 2005, Haematologica.

PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003

H. Serve, M. Schmid, M. Schaich, 2010 .

HLA-DRB3/4/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation

H. Einsele, N. Kröger, H. Schrezenmeier, 2021, Frontiers in Immunology.